Doximity (DOCS) Earnings Are In Focus As Fair Value Still Sits Higher

Simply Wall St.08-18 20:33

AdvertisementEarnings and Guidance Put Doximity Stock in Focus Doximity (DOCS) is in focus after first quarter earnings showed sales of US$156.62 million with lower net income of US$24.32 million, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2660498744?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","is_english":true,"pubTime":"2026-08-18 20:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2660498744","market":"us","top_or_hot":-1,"title":"Doximity (DOCS) Earnings Are In Focus As Fair Value Still Sits Higher","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementEarnings and Guidance Put Doximity Stock in Focus Doximity (DOCS) is in focus after first quarter earnings showed sales of US$156.62 million with lower net income of US$24.32 million, ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/doximity-docs-earnings-are-in-focus-as-fair-value-still-sits\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Doximity (DOCS) Earnings Are In Focus As Fair Value Still Sits Higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoximity (DOCS) Earnings Are In Focus As Fair Value Still Sits Higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-18 20:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/doximity-docs-earnings-are-in-focus-as-fair-value-still-sits><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementEarnings and Guidance Put Doximity Stock in Focus Doximity (DOCS) is in focus after first quarter earnings showed sales of US$156.62 million with lower net income of US$24.32 million, ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/doximity-docs-earnings-are-in-focus-as-fair-value-still-sits\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DOCS","symbol_name":"Doximity, Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/doximity-docs-earnings-are-in-focus-as-fair-value-still-sits","article_id":"2660498744","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-docs/doximity/news/doximity-docs-earnings-are-in-focus-as-fair-value-still-sits","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2660498744","pubTimestamp":1787056405,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Earnings and Guidance Put Doximity Stock in Focus\nDoximity (DOCS) is in focus after first quarter earnings showed sales of US$156.62 million with lower net income of US$24.32 million, alongside updated revenue guidance for the second quarter and full fiscal year.\nSee our latest analysis for Doximity.\nDoximity’s share price has climbed 27.31% over the past 90 days and 13.94% over the past month, yet remains down 43.36% year to date, while the 1 year total shareholder return is down 62.81%...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"DOCS":"Doximity, Inc."},"translate_title":"由于公允价值仍然较高，Doximity (DOCS) 盈利成为焦点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DOCS":1.5},"content_text":"AdvertisementEarnings and Guidance Put Doximity Stock in Focus Doximity (DOCS) is in focus after first quarter earnings showed sales of US$156.62 million with lower net income of US$24.32 million, alongside updated revenue guidance for the second quarter and full fiscal year. See our latest analysis for Doximity. Doximity’s share price has climbed 27.31% over the past 90 days and 13.94% over the past month, yet remains down 43.36% year to date, while the 1 year total shareholder return is down 62.81%. This points to improving short term momentum following a weak longer term record as investors weigh stronger sales against softer profitability and the updated revenue guidance. If you are assessing how this earnings reaction compares with other healthcare technology opportunities, it may be worth scanning 40 healthcare AI stocks Doximity’s share price has already rebounded sharply while earnings power looks softer than a year ago. Do the current expectations and updated revenue outlook still leave enough upside for new buyers, or is most of the reward now priced in? Most Popular Narrative: 27.2% Undervalued Based on the most followed narrative, Doximity’s fair value of $33.70 sits well above the recent $24.52 close, which frames the stock as materially undervalued in that narrative.  What I like about Doximity is that there really is a very high viewership / user base of active practicing Physicians in the US and that is not invaluable and definitely could be monetized perhaps more efficiently. I also think that Doximity offers a lot of interesting tools for Physicians a lot of which you’re free and really marketed towards I think Physicians who are more in private practice. It’s a little bit unclear how much value that provides given that most Physicians and practitioners these days are employed and not a private practice.  Read the complete narrative. According to Dc12, this valuation leans heavily on strong physician engagement, expectations for more effective monetization, and assumptions about steady margins and earnings from the healthcare software platform. The key question is how those usage patterns and profitability assumptions translate into long term cash flows and justify a fair value comfortably above today’s share price. Result: Fair Value of $33.70 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, stronger physician engagement will matter less if Doximity’s AI tools lose out to rivals or if monetization of that user base proves slower than hoped. Find out about the key risks to this Doximity narrative. Next Steps With mixed signals around Doximity’s recent performance and valuation story, it makes sense to move quickly and review the underlying details yourself. To see how the balance of potential risks and rewards stacks up before you decide what this earnings update means for you, take a closer look at the 2 key rewards and 2 important warning signs Looking for more investment ideas beyond Doximity? If this Doximity update has sharpened your focus, do not stop here. Use the Simply Wall St Screener to uncover stocks that better fit your goals.  Target potential upside by scanning companies that appear mispriced on fundamentals through the 53 high quality undervalued stocks. Strengthen your income stream by reviewing stocks that feature robust payouts in the 10 dividend fortresses. Prioritize capital preservation and consistency by checking companies highlighted in the 80 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2660498744","isCrawlerRequest":true}